Science Explorer Back to mapMap

Most cited papers from Bavarian Nordic (United States)

What are the most cited papers from Bavarian Nordic (United States)?

The most cited paper from Bavarian Nordic (United States) is "The changing epidemiology of human monkeypox—A potential threat? A systematic review" (Eveline M. Bunge, Bernard Hoet, Liddy M. Chen et al., 2022), with 1,977 citations. Next come "Cutting Edge: Generation of Splenic CD8+ and CD8− Dendritic Cell Equivalents in Fms-Like Tyrosine Kinase 3 Ligand Bone Marrow Cultures" (544) and "Human monkeypox – After 40 years, an unintended consequence of smallpox eradication" (327).

Showing 50 of 59 papers. Every paper with more than 10 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The changing epidemiology of human monkeypox—A potential threat? A systematic review Eveline M. Bunge, Bernard Hoet, Liddy M. Chen et al. · PLoS neglected tropical diseases ReviewOpen access 11 Feb 2022 1,977
2 Cutting Edge: Generation of Splenic CD8+ and CD8− Dendritic Cell Equivalents in Fms-Like Tyrosine Kinase 3 Ligand Bone Marrow Cultures Shalin H. Naik, Anna I. Proietto, Nicholas S. Wilson et al. · The Journal of Immunology Jun 2005 544
3 Human monkeypox – After 40 years, an unintended consequence of smallpox eradication Karl Simpson et al. · Vaccine Open access 13 May 2020 327
4 Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer James L. Gulley, Michael Borre, Nicholas J. Vogelzang et al. · Journal of Clinical Oncology Open access 28 Feb 2019 286
5 Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox Phillip R. Pittman, Matthew W. Hahn, HeeChoon S. Lee et al. · New England Journal of Medicine Open access 13 Nov 2019 262
6 Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection Christofer Samuelsson, Jürgen Hausmann, Henning Lauterbach et al. · Journal of Clinical Investigation Open access 15 Apr 2008 141
7 Is a Widely Cultivated Culinary-Medicinal Royal Sun Agaricus (the Himematsutake Mushroom) Indeed Agaricus blazei Murrill? Paul E. Stamets, Solomon P. Wasser, Augusto Ferreira da Eira et al. · International journal of medicinal mushrooms 2002 99
8 Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial Jason S. Richardson, Deborah M. Anderson, Jason Mendy et al. · The Lancet 30 Mar 2025 90
9 Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers Joseph M. Rootman, Pamela Kryskow, Kalin Harvey et al. · Scientific Reports Open access 18 Nov 2021 82
10 The mycelium of the Trametes versicolor (Turkey tail) mushroom and its fermented substrate each show potent and complementary immune activating properties in vitro Kathleen F. Benson, Paul E. Stamets, Renee Davis et al. · BMC Complementary and Alternative Medicine Open access Dec 2019 68
11 Integrative considerations during the COVID-19 pandemic Lise N. Alschuler, Andrew Weil, Randy Horwitz et al. · EXPLORE Open access 26 Mar 2020 67
12 Revised Overall Survival Analysis of a Phase II, Randomized, Double-Blind, Controlled Study of PROSTVAC in Men With Metastatic Castration-Resistant Prostate Cancer Philip W. Kantoff, James L. Gulley, Cesar Pico-Navarro · Journal of Clinical Oncology Open access 20 Sep 2016 65
13 Extracts of Polypore Mushroom Mycelia Reduce Viruses in Honey Bees Paul E. Stamets, Nicholas L. Naeger, Jay Daniel Evans et al. · Scientific Reports Open access 11 Sep 2018 64
14 Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine Elke Jordan, Steven J. Lawrence, Thomas Peter Meyer et al. · The Journal of Infectious Diseases 24 Jul 2020 62
15 Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial Nathaly Samy, Daniela Reichhardt, Darja Schmidt et al. · Vaccine 11 Feb 2020 61
16 One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines Heiko Ilchmann, Nathaly Samy, Daniela Reichhardt et al. · The Journal of Infectious Diseases Open access 17 Nov 2022 58
17 Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial Lauren C. Tindale, Jason S. Richardson, Deborah M. Anderson et al. · The Lancet 30 Mar 2025 57
18 Chlorinated Coumarins from the Polypore Mushroom Fomitopsis officinalis and Their Activity against Mycobacterium tuberculosis Chang Hwa Hwang, Birgit U. Jaki, Larry L. Klein et al. · Journal of Natural Products Open access 2 Oct 2013 57
19 The Potential of AI in Health Higher Education to Increase the Students’ Learning Outcomes Maria José Sousa, Francesca Dal Mas, António Miguel Pesqueira et al. · TEM Journal Open access 27 May 2021 53
20 Notes on Nutritional Properties of Culinary-Medicinal Mushrooms Paul E. Stamets · International journal of medicinal mushrooms 2005 48
21 Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer Peter Joseph DeMaria et al. · Journal for ImmunoTherapy of Cancer Open access Sep 2021 42
22 Adenoma with gastric differentiation (so-called pyloric gland adenoma) in a heterotopic gastric corpus mucosa in the rectum Michael W. Vieth, Ryoji Kushima, J. P. A. de Jonge et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 18 Apr 2005 40
23 Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice Susan P. Foy, Barbara Sennino, Tracy dela Cruz et al. · PLoS ONE Open access 24 Feb 2016 39
24 Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine Elke Jordan, Golam Kabir, Stephanie A. Schultz et al. · The Journal of Infectious Diseases Open access 20 Apr 2023 38
25 Effect of i.v. acetaminophen on total hip or knee replacement surgery: A case-matched evaluation of a national patient database Christian C. Apfel, Jonathan S. Jahr, Colleen Kelly et al. · American Journal of Health-System Pharmacy 5 Nov 2015 38
26 Removal of Escherichia coli from synthetic stormwater using mycofiltration Alex Taylor, Alicia Flatt, Marc W. Beutel et al. · Ecological Engineering 17 Jun 2014 38
27 MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings Lauren M.K. Mason, Estefania Betancur, Margarita Riera-Montes et al. · Vaccine ReviewOpen access 16 Oct 2024 36
28 Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells Susan P. Foy, Stefanie J. Mandl, Tracy dela Cruz et al. · Cancer Immunology Immunotherapy Open access 10 Mar 2016 35
29 The epidemiology of infectious diseases in Europe in 2020 versus 2017–2019 and the rise of tick-borne encephalitis (1995–2020) Victoria A. Jenkins, Guenter Silbernagl, Lorraine R. Baer et al. · Ticks and Tick-borne Diseases Open access 23 May 2022 32
30 Differential Immune Activating, Anti-Inflammatory, and Regenerative Properties of the Aqueous, Ethanol, and Solid Fractions of a Medicinal Mushroom Blend Renee Davis, Alex Taylor, Regan Nally et al. · Journal of Inflammation Research Open access Feb 2020 31
31 DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites Alexander James Bradshaw, Talia Backman, Virginia Ramírez-Cruz et al. · Applied and Environmental Microbiology Open access 29 Nov 2022 30
32 Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses Weigang Hu, Robin Steigerwald, Marcus Kalla et al. · Vaccine Open access 20 Jul 2018 28
33 Deterioration model and input parameters for reinforcement corrosion Matthias Beck, Andreas Bürkert, Jörg Harnisch et al. · Structural Concrete Open access Sep 2012 28
34 Ibuprofen in human milk Konstantin Pascal Walter, Carmen Dilger · British Journal of Clinical Pharmacology Aug 1997 28
35 Is a Widely Cultivated Culinary-Medicinal Royal Sun Agaricus (Champignon do Brazil, or the Himematsutake Mushroom) Agaricus brasiliensis S.Wasser et al. Indeed a Synonym of A. subrufescens Peck? Augusto Ferreira da Eira, Marina Ya. Didukh, Maria Angela Lopes de Almeida Amazonas et al. · International journal of medicinal mushrooms Open access 2005 27
36 Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells Stefanie J. Mandl, Ryan B. Rountree, Katie Dalpozzo et al. · Cancer Immunology Immunotherapy Open access 6 Aug 2011 27
37 Directed evolution of Metarhizium fungus improves its biocontrol efficacy against Varroa mites in honey bee colonies Jennifer O. Han, Nicholas L. Naeger, Brandon Kingsley Hopkins et al. · Scientific Reports Open access 19 May 2021 26
38 Exaggerated phosphorylation of brain tau protein in CRH KO mice exposed to repeated immobilization stress Richard Květňanský, Petr Novák, Peter Vargovič et al. · Stress Open access 3 Jul 2016 24
39 Enhanced Priming of Multispecific, Murine CD8+ T Cell Responses by DNA Vaccines Expressing Stress Protein-Binding Polytope Peptides Reinhold Schirmbeck, Nicolás Fissolo, Paul Chaplin et al. · The Journal of Immunology Open access Aug 2003 23
40 Dendritic Cells from Mice Neonatally Vaccinated with Modified Vaccinia Virus Ankara Transfer Resistance against Herpes Simplex Virus Type I to Naive One-Week-Old Mice Marco Franchini, Hanspeter Hefti, Sabine Vollstedt et al. · The Journal of Immunology May 2004 23
41 Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study Melinda J. Morton Hamer, James M McCarty, Benjamin C. Pierson et al. · The Lancet Microbe Open access 12 Feb 2025 19
42 A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN® vaccine in healthy adults Edgar Turner Overton, Darja Schmidt, Sanja Vidojkovic et al. · Vaccine Open access 29 Nov 2022 19
43 Engineering Analysis of Plant and Fungal Contributions to Bioretention Performance Alex Taylor, Jill Wetzel, Emma Mudrock et al. · Water Open access 12 Sep 2018 18
44 Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy Stefanie J. Mandl, Ryan B. Rountree, Tracy B dela Cruz et al. · Journal for ImmunoTherapy of Cancer Open access 9 Oct 2014 18
45 Antipox Properties of Fomitopsis officinalis (Vill.: Fr.) Bond. et Singer (Agarikon) from the Pacific Northwest of North America Paul E. Stamets · International journal of medicinal mushrooms 2005 18
46 Design model for reinforcement corrosion Kai Osterminski, P Schießl · Structural Concrete Sep 2012 17
47 Inducible expression of p21 WAF-1/CIP-1/SDI-1 from a promoter conversion retroviral vector Stefan Mrochen, Dieter Klein, Sigrid Nikol et al. · Journal of Molecular Medicine 17 Nov 1997 16
48 Techniques for the Cultivation of the Medicinal Mushroom Royal Sun Agaricus-Agaricus blazei Murr. (Agaricomycetideae) Paul E. Stamets · International journal of medicinal mushrooms 2000 16
49 Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma Guru Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor et al. · Cancer Immunology Immunotherapy Open access 23 Aug 2022 15
50 Bacteria evade immune recognition via TLR13 and binding of their 23S rRNA by MLS antibiotics by the same mechanisms Hubertus Hochrein, Carsten J. Kirschning · OncoImmunology Open access Mar 2013 15

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.